NCT02193503View on ClinicalTrials.gov

MVX-ONCO-1 in Patients With Solid Tumor

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2026

Conditions

Solid TumorCancer

Interventions

OTHER

Treatment

Treatment is the implantation of loaded capsules + injection of irradiated autologous tumor cells

Trial Locations (1)

1205

Hopitaux Universitaires de Genève - HUG, Geneva

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Maxivax SA

INDUSTRY